Glycaemic control and outcome in general intensive care: The East Anglian GLYCOGENIC study

British Journal of Intensive Care

Volumn 18, Issue 4, 2008, Pages 121-126

  Mackenzie, I M ^a,d   Ercole, A ^a   Blunt, M ^b   Ingle, S ^a   Palmer, C R ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NEUTRAL INSULIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBESITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 57849084963     PISSN: 09617930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients; a systematic overview. Stroke 2001; 32: 2426-2432.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes; a systematic overview. Lancet 2000; 355: 773-778.
3. Krinsley JS. Association between hyperglycaemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78: 1471-1478.
4. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367.
5. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000.
6. Dellinger RP, Carlet JM, Masur H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Cut Care Med 2004; 32; 858-873.
7. Mackenzie I, Ingle S, Zaidi S, Buczaski S. Tight glycaemic control; A survey of intensive care practice in large English hospitals. Intensive Care Med 2005; 31: 1136.
8. Bellomo R, Egi M. Glycemic control in the intensive care unit; why we should wait for NICE-SUGAR. Mayo Clin Proc 2005; 80: 1546-1548.
9. Angus DC, Abraham E. Intensive insulin therapy in critical illness. Am J Respir Crit Care Med 2005; 172: 1358-1359.
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II; a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
11. Rowan KM, Kerr JH, Major E, McPherson K, Short A, Vessey MP. Intensive Care Society's APACHE II study in Britain and Ireland. I; Variations in case mix of adult admissions to general intensive care units and impact on outcome. BMJ 1993; 307: 972-977.
12. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis - Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
13. Miranda DR, de Rijk A, Schaufeli W. Simplified Therapeutic Intervention Scoring System; the TISS-28 items - results from a multicenter study. Crit Care Med 1996; 24: 64-73.
14. Bhatia A, Cadman C, Mackenzie I. Hypoglycemia and cardiac arrest in a critically ill patient on strict glycemic control. Anesth Analg 2006; 102: 549-551.
15. Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J Clin Invest 2005; 115: 1111-1119.
16. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
17. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action and insulin secretion. Obes Res 2001; 9: 414-417.
18. Straczkowski M, Dzienis-Straczkowska S, Stepien A, Kowalskal, Szelachowska M, Kinalska I. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 2002; 87: 4602-4606.
19. Bercault N, Boulain T, Kuteifan K, Wolf M, Runge I, Fleury JC. Obesity-related excess mortality rate in an adult intensive care unit; A risk-adjusted matched cohort study. Crit Care Med 2004; 32: 998-1003.
20. Mackenzie I, Ingle S, Underwood C, Blunt M. Which measure of glycaemic control? Proc Am Thor Soc 2005; 2(abstracts); A37.
21. Vogelzang M, van der Horst IC, Nijsten MW. Hyperglycaemic index as a tool to assess glucose control; a retrospective study. Critical Care2004;8:R122-127.
22. Mackenzie I, Ingle S, Zaidi S, Buczaski S. Hypoglycaemia? So what! Intensive Care Med 2006; 32: 620-621.
23. Ingle S, Underwood C, Blunt M, Mackenzie I. Tight glycaemic control: Impact on nursing staff. Proc Am Thor Soc 2005; 2(abstracts); A38.
24. Schultz MJ, Spronk PE, Moeniralam HS. Tight glycaemic control; a survey of intensive care practice in the Netherlands. Intensive Care Med 2006; 32: 618-619.
25. American College of Chest Physicians/Societyof Critical Care Medicine. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.